Ticker Details
Gossamer Bio, Inc.
IPO Date:	February 4, 2019
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$75.62M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.26 | 4.26%
Avg Daily Range (30 D):	$0.02 | 12.60%
Avg Daily Range (90 D):	$0.02 | 8.73%

Institutional Daily Volume
Avg Daily Volume:	2.67M
Avg Daily Volume (30 D):	35.83M
Avg Daily Volume (90 D):	19.94M

Trade Size
Avg Trade Size (Sh.):	312
Avg Trade Size (Sh.) (30 D):	877
Avg Trade Size (Sh.) (90 D):	725

Institutional Trades
Total Institutional Trades:	1,354
Avg Institutional Trade:	$1.47M
Avg Institutional Trade (30 D):	$1.38M
Avg Institutional Trade (90 D):	$1.63M
Avg Institutional Trade Volume:	.32M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.71M
Avg Closing Trade (30 D):	$3.27M
Avg Closing Trade (90 D):	$3.27M
Avg Closing Volume:	384.33K

News

May 31, 2026 @ 10:59 PM GOSS Investors Have Opportunity to Lead Gossamer B... Source: The Schall Law Firm

May 31, 2026 @ 9:43 PM GOSS FINAL DEADLINE ALERT: Gossamer Bio Investors ... Source: Hagens Berman

May 30, 2026 @ 10:52 PM GOSS DEADLINE NOTICE: ROSEN, RECOGNIZED INVESTOR C... Source: Rosen Law Firm

May 29, 2026 @ 6:48 PM Gossamer Bio, Inc. (GOSS) Faces Securities Class A... Source: Hagens Berman

May 29, 2026 @ 4:52 PM GOSSAMER BIO DEADLINE MONDAY JUNE 1st: Bragar Eage... Source: Bragar Eagel & Squire, P.C.

Financials
	TTM	Q2 2026	Q1 2026
Basic EPS		$.05	$-.2
Diluted EPS		$-.08	$-.2
Revenue		$9.24M	$16.96M
Gross Profit
Net Income / Loss		$16.9M	$-46.66M
Operating Income / Loss		$-26.07M	$-44.87M
Cost of Revenue
Net Cash Flow		$.13M	$3.4M
PE Ratio